Preventing Opioid-Related Harms in the Construction Industry.

communications construction opioid crisis primary prevention training

Journal

New solutions : a journal of environmental and occupational health policy : NS
ISSN: 1541-3772
Titre abrégé: New Solut
Pays: United States
ID NLM: 9100937

Informations de publication

Date de publication:
11 2021
Historique:
pubmed: 9 4 2021
medline: 15 12 2021
entrez: 8 4 2021
Statut: ppublish

Résumé

The construction sector has been hit hard by the opioid crisis. We describe CPWR-The Center for Construction Research and Training's recent efforts to address the challenges of opioid use in the construction industry. With support and guidance from the North America's Building Trades Unions Opioid Task Force, CPWR undertook three projects to promote prevention and best practices for struggling construction workers. The first project focused on recommendations for communications that reframe stigmatizing narratives into effective messages about prevention solutions. The second project refined and distributed a one-hour construction worker opioid hazard awareness training module. The third project assessed opportunities and barriers for the expansion and improvement of existing union peer support programs to support workers through treatment and recovery. Additional resources, such as opioid hazard tool box talks, to help reverse the impact on the sector are also described.

Identifiants

pubmed: 33827351
doi: 10.1177/10482911211008174
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

367-372

Subventions

Organisme : CDC HHS
Pays : United States

Auteurs

Cora Roelofs (C)

CR Research/Consulting, Roxbury, MA, USA.

Christopher Rodman (C)

CPWR, Silver Spring, MD, USA.

Richard Rinehart (R)

CPWR, Silver Spring, MD, USA.

Chris Trahan Cain (CT)

CPWR, Silver Spring, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH